Evidence-Based Reviews

Becoming vaccine ambassadors: A new role for psychiatrists

Current Psychiatry. 2021 August;20(8):10-11,17-21,26-28,38 | doi:10.12788/cp.0155

References

1. Mazereel V, Van Assche K, Detraux J, et al. COVID-19 vaccination for people with severe mental illness: why, what, and how? Lancet Psychiatry. 2021;8(5):444-450.

2. Freudenreich O, Van Alphen MU, Lim C. The ABCs of successful vaccinations: a role for psychiatry. Current Psychiatry. 2021;20(3):48-50.

3. World Health Organization (WHO). Ten threats to global health in 2019. Accessed July 2, 2021. https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019

4. MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015;33(34):4161-4164.

5. McClure CC, Cataldi JR, O’Leary ST. Vaccine hesitancy: where we are and where we are going. Clin Ther. 2017;39(8):1550-1562.

6. Betsch C, Korn L, Holtmann C. Don’t try to convert the antivaccinators, instead target the fence-sitters. Proc Natl Acad Sci. 2015;112(49):E6725-E6726.

7. Rahman T, Hartz SM, Xiong W, et al. Extreme overvalued beliefs. J Am Acad Psychiatry Law. 2020;48(3):319-326.

8. Leask J. Target the fence-sitters. Nature. 2011;473(7348):443-445.

9. United States Census Bureau. Household Pulse Survey COVID-19 Vaccination Tracker. Updated June 30, 2021. Accessed July 2, 2021. https://www.census.gov/library/visualizations/interactive/household-pulse-survey-covid-19-vaccination-tracker.html

10. United States Census Bureau. Measuring household experiences during the coronavirus pandemic. Updated May 5, 2021. Accessed July 2, 2021. https://www.census.gov/data/experimental-data-products/household-pulse-survey.html

11. Jefsen OH, Kølbæk P, Gil Y, et al. COVID-19 vaccine willingness among patients with mental illness compared with the general population. Acta Neuropsychiatrica. 2021:1-24. doi:10.1017/neu.2021.15

12. Miles LW, Williams N, Luthy KE, et al. Adult vaccination rates in the mentally ill population: an outpatient improvement project. J Am Psychiatr Nurses Assoc. 2020;26(2):172-180.

13. Lewandowsky S, Ecker UK, Seifert CM, et al. Misinformation and its correction: continued influence and successful debiasing. Psychol Sci Public Interest. 2012;13(3):106-131.

14. Druss BG, Rosenheck RA. Locus of mental health treatment in an integrated service system. Psychiatr Serv. 2000;51(7):890-892.

15. Freudenreich O, Kontos N, Querques J. COVID-19 and patients with serious mental illness. Current Psychiatry. 2020;19(9):24-35.

16. Hamel L, Kirzinger A, Muñana C, et al. KFF COVID-19 vaccine monitor: December 2020. Accessed July 2, 2021. https://www.kff.org/coronavirus-covid-19/report/kff-covid-19-vaccine-monitor-december-2020/

17. Kai J, Crosland A. Perspectives of people with enduring mental ill health from a community-based qualitative study. Br J Gen Pract. 2001;51(470):730-736.

18. Mather G, Baker D, Laugharne R. Patient trust in psychiatrists. Psychosis. 2012;4(2):161-167.

19. Miller WR, Rollnick S. Motivational interviewing: helping people change. Guilford Press; 2012.

20. Reno JE, O’Leary S, Garrett K, et al. Improving provider communication about HPV vaccines for vaccine-hesitant parents through the use of motivational interviewing. J Health Commun. 2018;23(4):313-320.

21. Baddeley M. Behavioural economics: a very short introduction. Volume 505. Oxford University Press; 2017.

22. Nemani K, Li C, Olfson M, et al. Association of psychiatric disorders with mortality among patients with COVID-19. JAMA Psychiatry. 2021;78(4):380-386.

23. De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52.

24. Lorenz RA, Norris MM, Norton LC, et al. Factors associated with influenza vaccination decisions among patients with mental illness. Int J Psychiatry Med. 2013;46(1):1-13.

25. Bitan DT. Patients with schizophrenia are under‐vaccinated for COVID‐19: a report from Israel. World Psychiatry. 2021;20(2):300.

26. Robotham D, Satkunanathan S, Doughty L, et al. Do we still have a digital divide in mental health? A five-year survey follow-up. J Med Internet Res. 2016;18(11):e309.

27. De Hert M, Cohen D, Bobes J, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011;10(2):138.

28. Carrà G, Bartoli F, Carretta D, et al. The prevalence of metabolic syndrome in people with severe mental illness: a mediation analysis. Soc Psychiatry Psychiatr Epidemiol. 2014;49(11):1739-1746.

29. Lin MT, Burgess JF, Carey K. The association between serious psychological distress and emergency department utilization among young adults in the USA. Soc Psychiatry Psychiatr Epidemiol. 2012;47(6):939-947.

30. DeCoux M. Acute versus primary care: the health care decision making process for individuals with severe mental illness. Issues Ment Health Nurs. 2005;26(9):935-951.

31. Hoffman L, Wisniewski H, Hays R, et al. Digital opportunities for outcomes in recovery services (DOORS): a pragmatic hands-on group approach toward increasing digital health and smartphone competencies, autonomy, relatedness, and alliance for those with serious mental illness. J Psychiatr Pract. 2020;26(2):80-88.

32. Rosenberg SD, Goldberg RW, Dixon LB, et al. Assessing the STIRR model of best practices for blood-borne infections of clients with severe mental illness. Psychiatr Serv. 2010;61(9):885-891.

33. Slade EP, Rosenberg S, Dixon LB, et al. Costs of a public health model to increase receipt of hepatitis-related services for persons with mental illness. Psychiatr Serv. 2013;64(2):127-133.

34. Brewer NT, Chapman GB, Rothman AJ, et al. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18(3):149-207.

35. Nabet B, Gable J, Eder J, et al. PolicyLab evidence to action brief: addressing vaccine hesitancy to protect children & communities against preventable diseases. Children’s Hospital of Philadelphia. Published Spring 2017. Accessed July 2, 2021. https://policylab.chop.edu/sites/default/files/pdf/publications/Addressing_Vaccine_Hesitancy.pdf

36. Opel DJ, Heritage J, Taylor JA, et al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037-1046.

37. Betsch C, Böhm R, Korn L, et al. On the benefits of explaining herd immunity in vaccine advocacy. Nat Hum Behav. 2017;1(3):1-6.

38. Shen F, Sheer VC, Li R. Impact of narratives on persuasion in health communication: a meta-analysis. J Advert. 2015;44(2):105-113.

39. Parkerson N, Leader A. Vaccine hesitancy in the era of COVID. Population Health Leadership Series: PopTalk webinars. Paper 26. Published February 10, 2021. https://jdc.jefferson.edu/phlspoptalk/26/

40. Dempsey AF, O’Leary ST. Human papillomavirus vaccination: narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Acad Pediatr. 2018;18(2):S23-S27.

41. Chou W, Burgdorf C, Gaysynsky A, et al. COVID-19 vaccination communication: applying behavioral and social science to address vaccine hesitancy and foster vaccine confidence. National Institutes of Health. Published 2020. https://obssr.od.nih.gov/sites/obssr/files/inline-files/OBSSR_VaccineWhitePaper_FINAL_508.pdf

42. International Society for Vaccines and the MJH Life Sciences COVID-19 coalition. Building confidence in COVID-19 vaccination: a toolbox of talks from leaders in the field. March 9, 2021. https://globalmeet.webcasts.com/starthere.jsp?ei=1435659&tp_key=59ed660099

43. Centers for Disease Control and Prevention. Frequently asked questions about COVID-19 vaccination. Accessed July 2, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/faq.html

44. Singh BR, Gandharava S, Gandharva R. Covid-19 vaccines and community immunity. Infectious Diseases Research. 2021;2(1):5.

45. Goldfarb JL, Kreps S, Brownstein JS, et al. Beyond the first dose - Covid-19 vaccine follow-through and continued protective measures. N Engl J Med. 2021;85(2):101-103.

What makes psychiatrists ideal vaccine ambassadors?

There are several reasons psychiatrists can be well-positioned to contribute to the success of vaccination campaigns (Table 1). These include their frequent contact with patients and their care teams, the high trust those patients have in them, and their medical expertise and skills in applied behavioral and social science techniques, including motivational interviewing and nudging. Vaccination efforts and outreach are more effective when led by the clinician with whom the patient has the most contact because resolving vaccine hesitancy is not a one-time discussion but requires ongoing communication, persistence, and consistency.¹³ Patients may contact their psychiatrists more frequently than their other clinicians, including PCPs. For this reason, psychiatrists can serve as the gateway to health care, particularly for patients with SMI.¹⁴ In addition, interruptions in nonemergency services caused by the COVID-19 pandemic may affect vaccine delivery because patients may have been unable to see their PCPs regularly during the pandemic.¹⁵

Psychiatrists’ medical expertise and their ability to develop rapport with their patients promote trust-building. Receiving credible information from a trusted source such as a patient’s psychiatrist can be impactful. A recent poll suggested that individual health care clinicians have been consistently identified as the most trusted sources for vaccine information, including for the COVID-19 vaccines.¹⁶ There is also higher trust when there is greater continuity of care both in terms of length of time the patient has known the clinician and the number of consultations,¹⁷ an inherent part of psychiatric practice. In addition, research has shown that patients trust their psychiatrists as much as they trust their general practitioners.¹⁸

Psychiatrists are experts in behavior change, promoting healthy behaviors through motivational interviewing and nudging. They also have experience with managing patients who hold overvalued ideas as well as dealing with uncertainty, given their scientific and medical training.

Motivational interviewing is a patient-centered, collaborative approach widely used by psychiatrists to treat unhealthy behaviors such as substance use. Clinicians elicit and strengthen the patient’s desire and motivation for change while respecting their autonomy. Instead of presenting persuasive facts, the clinician creates a welcoming, nonthreatening, safe environment by engaging patients in open dialogue, reflecting back the patients’ concerns with empathy, helping them realize contradictions in behavior, and supporting self-sufficiency.¹⁹ In a nonpsychiatric setting, studies have shown the effectiveness of motivational interviewing in increasing uptake of human papillomavirus vaccines and of pediatric vaccines.²⁰

Nudging, which comes from behavioral economics and psychology, underscores the importance of structuring a choice architecture in changing the way people make their everyday decisions.²¹ Nudging still gives people a choice and respects autonomy, but it leads patients to more efficient and productive decision-making. Many nudges are based around giving good “default options” because people often do not make efforts to deviate from default options. In addition, social nudges are powerful, giving people a social reference point and normalizing certain behaviors.²¹ Psychiatrists have become skilled in nudging from working with patients with varying levels of insight and cognitive capabilities. That is, they give simple choices, prompts, and frequent feedback to reinforce “good” decisions and to discourage “bad” decisions.

Continue to: Managing overvalued ideas